نتایج جستجو برای: factor eight inhibitor bypassing activity

تعداد نتایج: 2125544  

Journal: :Psychophysiology 2018
Eric S Drollette Matthew B Pontifex Lauren B Raine Mark R Scudder R Davis Moore Shih-Chun Kao Daniel R Westfall Chien-Ting Wu Keita Kamijo Darla M Castelli Naiman A Khan Arthur F Kramer Charles H Hillman

The present study investigated the effect of a 9-month physical activity (PA) intervention on children's cardiorespiratory fitness levels and neuroelectric indices of conflict monitoring (i.e., error-related negativity, ERN). Four hundred twenty-eight preadolescent children (8-9 years old) were randomized into a PA intervention or wait-list control group, and completed a fitness and cognitive c...

Journal: :Japanese Journal of Thrombosis and Hemostasis 2003

Journal: :Neurology 2003
Paul Merkus Henk-Jan Guchelaar D Andries Bosch Frans W H M Merkus

It has been suggested that intranasal (IN) drug delivery could be used to administer drugs directly to the brain, bypassing the blood-brain barrier. Conclusive evidence of this proposed route of drug transport has not been observed by IN-IV comparison. In eight neurosurgery patients with a CSF drain, the uptake in CSF and plasma after IN and IV drug administration was compared. No evidence of d...

Journal: :Clinical Microbiology and Infection 1997

Ali Bijani, Amereh Hadizadeh, Hassan Mahmoodi Nesheli,

Background: Inhibitory antibody to exogenous Factor VIII (FVIII) is a major complication of hemophilia treatment. This study was conducted to determine the prevalence of inhibitor antibody directed against FVIII.Methods: From May 2010 to May 2011, 52 patients with severe hemophilia A admitted in Amirkola Children’s Hospital were evaluated. Those who had abnormal mixing study, antibody against F...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2008
I Tamaskar R Bukowski P Elson A G Ioachimescu L Wood R Dreicer T Mekhail J Garcia B I Rini

BACKGROUND Sorafenib is an orally bioavailable vascular endothelial growth factor receptor (VEGFR) inhibitor with antitumor activity in metastatic renal cell carcinoma (RCC). Sunitinib, also a VEGFR inhibitor, induces biochemical hypothyroidism in 85% of metastatic RCC patients, the majority of whom have signs or symptoms of hypothyroidism. Hence, the incidence of thyroid function test (TFT) ab...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید